placebo alcohol
Preclinical
placebo alcohol is one of 5 therapeutic programs targeting Impairment. It is currently in Preclinical.
1
Indications
2
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
5 competitors in Impairment
#DrugCompanyPhaseTrials
1LY3537031
Eli LillyPhase 1
Xe-133
NNobilis Therapeutics Inc.
Preclinical
Alcohol
AstellasPreclinical
placebo alcohol
CCentre for Addiction and Mental Health
Preclinical
Delta-9-Tetrahydrocannabinol
CCentre for Addiction and Mental Health
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for placebo alcohol. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]